Kristin oversees the financial wellness of VMS BioMarketing, in addition to all support functions within the organization to ensure upward-trending growth.
Kristin is committed to maximizing long-term financial growth, ensuring a balanced portfolio of growth initiatives, and driving all support functions to maintain the high level of integrity and transparency for which VMS is known. She brought her financial and human resources expertise and executive leadership skills to VMS BioMarketing in 2016 when she took on the role of Chief Financial Officer and expanded her duties in 2017 adding oversight of all support functions.
Involved in life sciences for over 25 years, Kristin's previous experience is filled with a number of executive leadership roles. She served as Chief Financial Officer for private biotech companies including Calibrium, LLC, which was sold to Novo Nordisk, and Marcadia Biotech, which was acquired by Roche. In addition, Kristin held a variety of influential finance roles for Guidant Corporation including Vice President and Treasurer during the company's sale to Boston Scientific.
Kristin earned her BA in economics from DePauw University, achieving Summa Cum Laude distinction, and her MBA from The Tuck School of Business at Dartmouth, achieving Tuck Scholar distinction. She currently serves as a board member for LDI Ltd., LLC. as well as a board member and treasurer for Community Health Network. Kristin is also chair of the Audit, Compliance, and Finance Committee for Community Health Network.